QDEM PHARMACEUTICALS LIMITED

07841452
Active Cambridge

Wholesale of pharmaceutical goods

0 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Q

QDEM PHARMACEUTICALS LIMITED

07841452

Wholesale of pharmaceutical goods

Founded 9 Nov 2011 Active Cambridge, England 0 employees website.com
Life sciences and medical technology Wholesale of pharmaceutical goods
Accounts Submitted 8 Sept 2025 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 9 Jun 2026 Next due 12 Jun 2027 11 months remaining
Net assets £5M £293K 2023 year on year
Total assets £8M £5M 2023 year on year
Total Liabilities £3M £5M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 191 Cambridge Science Park Milton Road Cambridge CB4 0GW England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for QDEM PHARMACEUTICALS LIMITED (07841452), an active life sciences and medical technology company based in Cambridge, England. Incorporated 9 Nov 2011. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2014–2023)

Cash in Bank

£3.00k

Net Assets

£5.14M

Increased by £293.00k (+6%)

Total Liabilities

£2.68M

Decreased by £5.12M (-66%)

Turnover

£25.30M

Decreased by £9.28M (-27%)

Employees

N/A

Debt Ratio

34%

Decreased by 28 (-45%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (4)

Napp Pharmaceutical Holdings Limited
99.6%
Pacific Moon Corp
0.2%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

QDEM PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jun 2026Confirmation StatementConfirmation statement made on 29 May 2026 with no updates
17 Nov 2025OfficersChange to director Mr Stephen Johan Jamieson on 5 Nov 2025
14 Oct 2025OfficersTermination of Allison Hogg as director on 30 Sept 2025
8 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
29 May 2025Confirmation StatementConfirmation statement made on 29 May 2025 with no updates
9 Jun 2026 Confirmation Statement

Confirmation statement made on 29 May 2026 with no updates

17 Nov 2025 Officers

Change to director Mr Stephen Johan Jamieson on 5 Nov 2025

14 Oct 2025 Officers

Termination of Allison Hogg as director on 30 Sept 2025

8 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

29 May 2025 Confirmation Statement

Confirmation statement made on 29 May 2025 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 29 May 2026 with no updates

3 weeks ago on 9 Jun 2026

Change to director Mr Stephen Johan Jamieson on 5 Nov 2025

7 months ago on 17 Nov 2025

Termination of Allison Hogg as director on 30 Sept 2025

8 months ago on 14 Oct 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 8 Sept 2025

Confirmation statement made on 29 May 2025 with no updates

1 years ago on 29 May 2025